Tag Archives: cancer

Cato at the 12th World Congress on Gastrointestinal Cancer

Posted on 30 June 2010 by Evan Richardson

Cato Research will be attending the European Society for Medical Oncology‘s (ESMO)  12th World Congress on Gastrointestinal Cancer in Barcelona, Spain from 30 June to 03 July 2010.  ESMO is the leading European professional organization representing medical oncologists.  The conference … Continue reading →

Posted in Conferences and Meetings | Tagged , , , , , , | Comments Off

Cato at the Cancer Vaccines Meeting

Posted on 29 June 2010 by Evan Richardson

This week, Cato Research is attending the Cancer Vaccines meeting in Cambridge, MA on 29 and 30 June.  The conference is the first meeting dedicated to progressing cancer vaccines to market and will feature 21 of the world’s leading experts … Continue reading →

Posted in Conferences and Meetings | Tagged , , , , , , | Comments Off

LIPID MAPS 2010 Annual Meeting

Posted on 20 May 2010 by Ask-Cato.com Contributor

The LIPID Metabolites and Pathway Strategy (MAPS) Annual Meeting was held at UCSD in La Jolla, CA from03-04 May 2010.  LIPID MAPS was created in 2003 as a multidisciplinary effort to identify and quantitate all of the major (and some … Continue reading →

Posted in Conferences and Meetings | Tagged , , , , , , , , , , , , , , , , , , | Comments Off

Approval of Therapeutic Cancer Vaccines

Posted on 12 May 2010 by Ask-Cato.com Contributor

Last month, Dendreon was granted approval for Provenge®, the first cell based cancer vaccine for treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.  Provenge is the first cancer treatment that utilizes the strength of the … Continue reading →

Posted in FDA, Industry News, Publications | Tagged , , , , , , , , , , , , , , , , , , , | 1 Comment